Fibrous tubular conduit for stenting applications
US-2024189124-A1 · Jun 13, 2024 · US
US10022252B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10022252-B2 |
| Application number | US-201615012274-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 1, 2016 |
| Priority date | Jun 10, 2015 |
| Publication date | Jul 17, 2018 |
| Grant date | Jul 17, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A spiral blood flow device includes a stent made up of a plurality of expansion members joined to a plurality of axial members that permit the stent to change diameter among a continuum of expanded configurations. The axial members have fixed orientation, whereas the expansion members have a variable orientation relative to the longitudinal axis throughout the continuum of expanded configurations. A spiral flow inducing structure, which may include fins attached to the axial members, define a helical flow angle that remains constant throughout the continuum of expanded configurations.
Opening claim text (preview).
What is claimed is: 1. A spiral blood flow device comprising: a stent having a longitudinal axis and being movable among a transport configuration and a continuum of expanded configurations; the stent including a plurality of expansion members joined to a plurality of axial members, and wherein each of the axial members have a fixed orientation relative to the longitudinal axis throughout the continuum of expanded configurations, and the expansion members each have a variable orientation relative to the longitudinal axis throughout the continuum of expanded configurations; a spiral flow inducing structure attached to each of the plurality of axial members defining a helical flow angle relative to the longitudinal axis; and the helical flow angle being a constant throughout the continuum of expanded configurations. 2. The spiral blood flow device of claim 1 wherein each of the spiral flow inducing structures includes a fin attached at one edge to a respective one of the plurality of axial members. 3. The spiral blood flow device of claim 2 wherein each of the fins is identically shaped. 4. The spiral blood flow device of claim 3 wherein each of the fins is attached at exactly one attachment to the respective one of the plurality of axial members. 5. The spiral blood flow device of claim 1 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis throughout the continuum of expanded configurations. 6. The spiral blood flow device of claim 5 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis in the transport configuration. 7. The spiral blood flow device of claim 6 wherein each of the spiral flow inducing structures includes a fin attached at one edge to a respective one of the plurality of axial members. 8. The spiral blood flow device of claim 7 wherein each of the fins is identically shaped. 9. The spiral blood flow device of claim 1 wherein each of the plurality of axial members is attached at opposite ends to vertices that change shape throughout the continuum of expanded configurations. 10. The spiral blood flow device of claim 1 wherein each of the plurality of axial members has a vessel contact surface radially remote from the longitudinal axis. 11. The spiral blood flow device of claim 1 wherein the stent is a self expanding stent. 12. The spiral blood flow device of claim 11 wherein a diameter of the self expanding stent ranges from 2 mm to 6 mm over the continuum of expanded configurations. 13. The spiral blood flow device of claim 1 wherein each of the plurality of axial members is orientated parallel to the longitudinal axis in the transport configuration and throughout the continuum of expanded configurations; wherein each of the plurality of axial members is attached at opposite ends to vertices that change shape throughout the continuum of expanded configurations, and each of the plurality of axial members has a vessel contact surface radially remote from the longitudinal axis; wherein each of the spiral flow inducing structures includes a fin attached at one edge to a respective one of the plurality of axial members, and each of the fins is identically shaped; and wherein the stent is a self expanding stent. 14. A method of impeding neointimal hyperplasia with a spiral blood flow device that includes a stent having a longitudinal axis and being movable among a transport configuration and a continuum of expanded configurations; the stent including a plurality of expansion members joined to a plurality of axial members, and wherein each of the axial members have a fixed orientation relative to the longitudinal axis throughout the continuum of expanded configurations, and the expansion members each have a variable orientation relative to the longitudinal axis throughout the continuum of expanded configurations; a spiral flow inducing structure attached to each of the plurality of axial members defining a helical flow angle relative to the longitudinal axis; and the helical flow angle being a constant throughout the continuum of expanded configurations, and the method comprising the steps of: moving the spiral blood flow device in the transport configuration to an implantation site; implanting the spiral blood flow device at the implantation site at least in part by expanding the stent to a first diameter in the continuum of expanded configurations; inducing spiral flow in blood flowing through the spiral blood flow device with the spiral flow inducing structure; changing the spiral blood flow device from the first diameter to a second diameter in the continuum of expanded configurations responsive to a vessel diameter increase at the implantation site; and maintaining the helical flow angle constant throughout the change from the first diameter to the second diameter. 15. The method of claim 14 wherein the implanting step includes releasing the spiral blood flow device to self expand at the implantation site. 16. The method of claim 15 wherein the implanting step includes moving the plurality of axial members of the stent into contact with a vessel wall, and deploying a plurality of fins of the spiral flow inducing structure to define the helical flow angle. 17. The method of claim 16 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis throughout the change from the first diameter to the second diameter. 18. The method of claim 17 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis in the transport configuration. 19. The method of claim 18 wherein each of the plurality of axial members is attached at opposite ends to vertices that change shape during the implanting step and during the change from the first diameter to the second diameter. 20. The method of claim 19 wherein the continuum of expanded configurations corresponds to a diameter of the stent ranging from 2 mm to 6 mm.
Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure · CPC title
the wire-like elements comprising two or more adjacent rings flexibly connected by separate members · CPC title
Modifying the blood flow model, e.g. by diffuser or deflector · CPC title
Additional features; Implant or prostheses properties not otherwise provided for · CPC title
Adjacent bands being connected to each other · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.